SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Laurantis Pharma Oy and Ark Therapeutics Sign Manufacturing Agreement for Production of Lymfactin™ Investigational Treatment for Breast Cancer-Associated Lymphedema